Nektar Therapeutics
NKTR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $44 | $35 | $88 | $25 |
| Short-Term Investments | $211 | $268 | $417 | $709 |
| Receivables | $2 | $2 | $8 | $22 |
| Inventory | $0 | $16 | $19 | $16 |
| Other Curr. Assets | $4 | $9 | $13 | $23 |
| Total Curr. Assets | $261 | $331 | $546 | $796 |
| Property Plant & Equip (Net) | $12 | $37 | $86 | $178 |
| Goodwill | $0 | $0 | $77 | $77 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $26 | $26 | $0 | $65 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $5 | $2 | $3 |
| Total NC Assets | $43 | $67 | $165 | $322 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $304 | $398 | $711 | $1,117 |
| Liabilities | – | – | – | – |
| Payables | $12 | $10 | $13 | $10 |
| Short-Term Debt | $20 | $19 | $19 | $17 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $30 | $22 | $37 | $58 |
| Total Curr. Liab. | $61 | $51 | $68 | $85 |
| LT Debt | $83 | $99 | $113 | $126 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $99 | $117 | $163 | $227 |
| Total NC Liab. | $182 | $216 | $276 | $352 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $103 | $118 | $131 | $143 |
| Total Liabilities | $243 | $267 | $344 | $438 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$3,596 | -$3,477 | -$3,201 | -$2,833 |
| AOCI | $0 | $0 | -$7 | -$4 |
| Other Equity | $3,657 | $3,608 | $3,575 | $3,517 |
| Total Equity | $61 | $131 | $367 | $680 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $304 | $398 | $711 | $1,117 |
| Net Debt | $58 | $82 | $43 | $118 |